These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38990100)

  • 1. Update on antineutrophil cytoplasmic autoantibody vasculitis in children.
    Bloom JL; Wu EY
    Curr Opin Rheumatol; 2024 Sep; 36(5):336-343. PubMed ID: 38990100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibody-associated vasculitis.
    Konda R; Rajasekaran A; Rizk DV
    Curr Opin Nephrol Hypertens; 2024 Sep; 33(5):503-511. PubMed ID: 38785128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of ANCA-associated vasculitis.
    Holle JU; Wieczorek S; Gross WL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):609-21. PubMed ID: 20688253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.
    Robson JC; Milman N; Tomasson G; Dawson J; Cronholm PF; Kellom K; Shea J; Ashdown S; Boers M; Boonen A; Casey GC; Farrar JT; Gebhart D; Krischer J; Lanier G; McAlear CA; Peck J; Sreih AG; Tugwell PS; Luqmani RA; Merkel PA
    J Rheumatol; 2015 Nov; 42(11):2204-9. PubMed ID: 26329344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on ANCA-associated vasculitis: from biomarkers to therapy.
    Tedesco M; Gallieni M; Pellegata F; Cozzolino M; Alberici F
    J Nephrol; 2019 Dec; 32(6):871-882. PubMed ID: 31301058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis.
    Tomasson G
    Curr Opin Rheumatol; 2015 Jan; 27(1):38-44. PubMed ID: 25405826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.
    Li W; Huang H; Cai M; Yuan T; Sheng Y
    Front Immunol; 2021; 12():624848. PubMed ID: 33841406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
    Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
    Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic vasculitis and the lung.
    Talarico R; Barsotti S; Elefante E; Baldini C; Tani C; Mosca M
    Curr Opin Rheumatol; 2017 Jan; 29(1):45-50. PubMed ID: 27755177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can antineutrophil cytoplasmic antibody levels be used to inform treatment of pauci-immune vasculitis?
    Fussner LA; Specks U
    Curr Opin Rheumatol; 2015 May; 27(3):231-40. PubMed ID: 25775187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
    Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
    Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?
    Kallenberg CG
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):1-3. PubMed ID: 21447120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasm antibody-associated vasculitis: recent developments.
    Furuta S; Jayne DR
    Kidney Int; 2013 Aug; 84(2):244-9. PubMed ID: 23423257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.
    Plumb LA; Oni L; Marks SD; Tullus K
    Pediatr Nephrol; 2018 Jan; 33(1):25-39. PubMed ID: 28062909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K; Mandell BF
    Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis.
    Walsh M
    Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):555-9. PubMed ID: 25144513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortitis caused by antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a case-based review.
    Skeik N; Hari G; Nasr R
    Rheumatol Int; 2019 Nov; 39(11):1983-1988. PubMed ID: 31222438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.